Results 181 to 190 of about 44,419 (235)

<i>BRCA2</i> Reversion Mutation after Neoadjuvant Dose-Dense EC and Dose-Dense Paclitaxel in Triple-Negative Breast Cancer: A Case Report and Literature Review. [PDF]

Surg Case Rep
Hikino H, Otani A, Makino Y.
europepmc   +1 more source

Integrating breast tumour homologous recombination deficiency status to aid germline BRCA1 and BRCA2 variant classification. [PDF]

EBioMedicine
Fortuno C, Zhang J, Koufariotis LT, Hollway G, Wood S, Pearson JV, Simpson PT, Lakhani SR, McCart Reed AE, Thorne H, Mann GB, Skandarajah AR, Devereux L, Zhao Q, De Silva DL, Lindeman GJ, Waring P, James PA, Campbell I, Spurdle AB, Waddell N.   +20 more
europepmc   +1 more source

Breast cancer susceptibility gene 2 upregulation alleviated cardiac hypertrophy in angiotensin II-treated mice. [PDF]

Biochem Biophys Rep
Liu K, Gong XX, Li Y, Li MZ, Si C, Zhou L.   +5 more
europepmc   +1 more source

Presence and prevalence of single nucleotide sequence polymorphisms in <i>TP53</i> and <i>BRCA2</i> genes as of cervical and ovarian cancers in women using hormonal contraceptives in Abuja, Nigeria. [PDF]

J Public Health Afr
Odebiyi OF, Kehinde A, Abdulsalami MS, Dibal DM.   +3 more
europepmc   +1 more source

Comparative Analysis of <i>BRCA</i> Pathogenic Variant Detection in a Real-World Setting: Population Screening Versus Oncogenetic Clinics. [PDF]

JCO Precis Oncol
Armon S, Lieberman S, Michaelson-Cohen R, Tomer A, Koller-Volkow E, Levy-Lahad E, Srebnik N.   +6 more
europepmc   +1 more source

Natural menopause, menarche and breast cancer risk in BRCA1 and BRCA2 pathogenic variant carriers: a Mendelian randomization analysis. [PDF]

Br J Cancer
Mavaddat N, Barnes DR, Michailidou K, Zhao E, Frost D, Leslie G, Dennis J, Wang Q, Bolla MK, EMBRACE, Evans DG, Tischkowitz M, Thompson DJ, Perry JRB, Antoniou AC, Easton DF.   +15 more
europepmc   +1 more source

Correction: Cosegregation analysis following an excellent response to olaparib in a pancreatic cancer patient carrier of BRCA2:c.7892 T > C variant enables its reclassification from VUS to pathogenic. [PDF]

BJC Rep
Strojnik K, Blatnik A, Krajc M, Novaković A, Ignjatović M, Ocvirk J, Stegel V, Škerl P, Klančar G, Novaković S, Šetrajčič Dragoš V.   +10 more
europepmc   +1 more source

Higher Levels of <i>BRCA1</i> Gene Methylation in Sporadic Breast Cancer Patients with a Lower Incidence of Recurrence. [PDF]

Med Sci (Basel)
Agnes G, Damin APS, Watte G, Guimarães GR, Roehe AV, Saffi J.   +5 more
europepmc   +1 more source

Risks of non-breast, non-ovarian cancers for BRCA1 and BRCA2 pathogenic variant carriers: a prospective cohort study. [PDF]

BMC Med
Yang R, MacInnis RJ, Milne RL, Nguyen-Dumont T, Maxwell WF, Genkinger JM, Glendon G, Kathleen Cuningham Foundation Consortium for Research Into Familial Breast Cancer (kConFab), Ross EA, Andrulis IL, Colonna SV, Daly M, John EM, Kurian AW, Terry MB, Hopper JL, Southey MC, Phillips KA, Li S.   +18 more
europepmc   +1 more source

Identification of Genetic Variants Among Breast Cancer Patients and At-Risk Individuals: A Cohort Study in Sri Lanka. [PDF]

Breast Cancer (Auckl)
Yatawara L, Hewavithana B, Ramanayake AP, Wickramasinghe S, Amarasiri M.   +4 more
europepmc   +1 more source